Literature DB >> 760657

Photochemotherapy for mycosis fungoides: a clinical and histological study.

N J Lowe, D J Cripps, P A Dufton, C F Vickers.   

Abstract

Nine patients with stages 2 or 3 mycosis fungoides (MF) and one with Sézary's syndrome were treated with oral methoxsalen and long-wave ultraviolet light. Previous therapy had either failed or achieved only partial control. Satisfactory clinical control was achieved in all but one case. Histological improvement was seen in all cases, but complete clearance of lymphoid infiltrate was noted mainly in epidermal and papillary dermal infiltrates. Lower dermal infiltrate remained largely unchanged. The case of Sézary's syndrome was inadequately controlled with systemic prednisone and cyclophosphamide, but addition of photochemotherapy improved the erythema and pruritus. This shows that photochemotherapy may have a place in MF treatment both alone and perhaps in conjunction with other treatments. An early relapse occurred on stopping photochemotherapy in four cases, but one patient has had three months' full remission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760657

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Mycosis fungoides--unsolved problems.

Authors: 
Journal:  Br Med J       Date:  1979-08-18

2.  PUVA-treatment for solar urticaria and persistent light reaction.

Authors:  E Hölzle; C Hofmann; G Plewig
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic.

Authors:  E J Yurkow; J D Laskin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review.

Authors:  Halle Field; Ling Gao; Pooja Motwani; Henry K Wong
Journal:  Dermatol Ther (Heidelb)       Date:  2016-09-02

5.  Commentary to "Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms" by Y. Masuda et al.

Authors:  H Hönigsmann
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-10       Impact factor: 6.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.